These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 20400233)
1. The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma. Karabork A; Kaygusuz G; Ekinci C Pathol Res Pract; 2010 Aug; 206(8):572-7. PubMed ID: 20400233 [TBL] [Abstract][Full Text] [Related]
2. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver. Morrison C; Marsh W; Frankel WL Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008 [TBL] [Abstract][Full Text] [Related]
3. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Lau SK; Prakash S; Geller SA; Alsabeh R Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology. Saad RS; Luckasevic TM; Noga CM; Johnson DR; Silverman JF; Liu YL Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137 [TBL] [Abstract][Full Text] [Related]
5. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates. Wang L; Vuolo M; Suhrland MJ; Schlesinger K Acta Cytol; 2006; 50(3):257-62. PubMed ID: 16780018 [TBL] [Abstract][Full Text] [Related]
6. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel. Saleh HA; Aulicino M; Zaidi SY; Khan AZ; Masood S Diagn Cytopathol; 2009 Mar; 37(3):184-90. PubMed ID: 19170172 [TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver. Lei JY; Bourne PA; diSant'Agnese PA; Huang J Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic significance of aquaporin-1 in liver tumors. Mazal PR; Susani M; Wrba F; Haitel A Hum Pathol; 2005 Nov; 36(11):1226-31. PubMed ID: 16260277 [TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas. Stroescu C; Herlea V; Dragnea A; Popescu I J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226 [TBL] [Abstract][Full Text] [Related]
10. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. Xiao SY; Wang HL; Hart J; Fleming D; Beard MR Am J Pathol; 2001 Oct; 159(4):1415-21. PubMed ID: 11583969 [TBL] [Abstract][Full Text] [Related]
11. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver. Ahuja A; Gupta N; Kalra N; Srinivasan R; Chawla Y; Rajwanshi A Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122 [TBL] [Abstract][Full Text] [Related]
12. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls. Geramizadeh B; Boub R; Rahsaz M Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. Lin F; Abdallah H; Meschter S Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758 [TBL] [Abstract][Full Text] [Related]
14. Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma. Wieczorek TJ; Pinkus JL; Glickman JN; Pinkus GS Am J Clin Pathol; 2002 Dec; 118(6):911-21. PubMed ID: 12472285 [TBL] [Abstract][Full Text] [Related]
15. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples. Lugli A; Tornillo L; Mirlacher M; Bundi M; Sauter G; Terracciano LM Am J Clin Pathol; 2004 Nov; 122(5):721-7. PubMed ID: 15491968 [TBL] [Abstract][Full Text] [Related]
16. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma]. Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the CD34 and CD10 immunostains using a two-color staining protocol in liver fine-needle aspiration biopsies. Zimmerman RL; Logani S; Baloch Z Diagn Cytopathol; 2005 Feb; 32(2):88-91. PubMed ID: 15637673 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma]. Dong H; Cong WL; Zhu ZZ; Wang B; Xian ZH; Yu H Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):702-5. PubMed ID: 19173916 [TBL] [Abstract][Full Text] [Related]
19. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Su YC; Hsu YC; Chai CY Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563 [TBL] [Abstract][Full Text] [Related]
20. Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma. Abdul-Al HM; Wang G; Makhlouf HR; Goodman ZD Int J Surg Pathol; 2010 Oct; 18(5):313-8. PubMed ID: 20444731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]